Harfouch-Hammoud E, Timsit J, Boitard C, Bach J F, Caillat-Zucman S
INSERM U25 and Service d'Immunologie Clinique, Hôpital Necker, Paris, France.
J Autoimmun. 1996 Jun;9(3):411-4. doi: 10.1006/jaut.1996.0056.
Certain DQ alpha/beta dimeric molecules have been shown to play a major role in determining susceptibility or resistance to IDDM. Whether or not predisposition associated with DR4 haplotypes is exclusively due to linkage to DQB10302 and DQA10301 alleles is still a controversial issue. A modifying effect of certain DRB104 subtypes on the susceptibility encoded by DQ alleles is possible, since not all DRB104-DQB10302 haplotypes are associated with the disease. The distribution of DRB104 subtypes was analysed in 240 DR4-positive Caucasian IDDM patients and 110 DR4-positive healthy controls using allele-specific hybridization after genomic amplification. Although an important contribution to IDDM predisposition was encoded by the DQB10302 allele which was found in the majority of patients (94.2% vs 64.7% in controls, Odd's ratio OR = 8.8, P < 0.0001), differences between DRB104 variants persisted after the effect of the DQB1 locus was removed by matching patients and controls for DQB10302. Thus, the DRB10402 allele conferred a strong IDDM-predisposing effect (OR = 3.1, P < 0.02) which was highly significant in the absence of DR3 on the second haplotype (OR = 5.6, P < 0.0001) but was not visible among DR3/4 heterozygote individuals. Conversely, the DRB10404 allele conferred a strong protective effect (OR = 0.26, P < 0.0001) which was dominant even in the presence of the associated high risk DR3 haplotype (OR = 0.21, P < 0.03). These data indicate that DQ molecules are not the sole contributors to the DR4-associated IDDM predisposition, and that peculiar DR4 subtypes play a significant role in susceptibility to or protection from the disease. DRB10402 differs from DRB1*0404 by only two acidic residues at positions 70 and 71 within the peptide binding groove, instead of amide and basic amino acids. This might induce changes of peptide binding specificity that correlate with the genetic linkage of IDDM predisposition.
某些DQα/β二聚体分子已被证明在决定对胰岛素依赖型糖尿病(IDDM)的易感性或抗性方面起主要作用。与DR4单倍型相关的易感性是否完全归因于与DQB10302和DQA10301等位基因的连锁,仍然是一个有争议的问题。某些DRB104亚型对DQ等位基因编码的易感性可能有修饰作用,因为并非所有DRB104-DQB10302单倍型都与该疾病相关。在240例DR4阳性的白种人IDDM患者和110例DR4阳性的健康对照中,采用基因组扩增后的等位基因特异性杂交分析了DRB104亚型的分布。尽管DQB10302等位基因对IDDM易感性有重要贡献,该等位基因在大多数患者中出现(94.2%对比对照组中的64.7%,优势比OR = 8.8,P < 0.0001),但在通过使患者和对照匹配DQB10302消除DQB1位点的影响后,DRB104变体之间的差异仍然存在。因此,DRB10402等位基因赋予了强烈的IDDM易感性效应(OR = 3.1,P < 0.02),在第二个单倍型上不存在DR3时该效应非常显著(OR = 5.6,P < 0.0001),但在DR3/4杂合个体中不明显。相反,DRB10404等位基因赋予了强烈的保护作用(OR = 0.26,P < 0.0001),即使在存在相关的高风险DR3单倍型时该作用也占主导(OR = 0.21,P < 0.03)。这些数据表明,DQ分子不是与DR4相关的IDDM易感性的唯一因素,并且特定的DR4亚型在该疾病的易感性或保护中起重要作用。DRB10402与DRB1*0404仅在肽结合槽内第70和71位有两个酸性残基不同,而不是酰胺和碱性氨基酸。这可能诱导与IDDM易感性的遗传连锁相关的肽结合特异性变化。